HIV-1 Latency Is Maintained by the Estrogen Receptor

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• The persistent latent reservoir of HIV is a major obstacle to achieving a complete cure for HIV infection.
• Understanding the molecular mechanisms that maintain viral latency is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To identify novel regulators of HIV latency using a large-scale screening approach.
• To investigate the role of the estrogen receptor in controlling proviral reactivation.

Main Methods:

• Utilized short hairpin RNA (shRNA) screening to systematically assess genes involved in HIV latency.
• Employed molecular assays to measure proviral reactivation in the presence and absence of estrogen receptor modulation.

Main Results:

• shRNA screening identified the estrogen receptor as a significant repressor of HIV proviral reactivation.
• Experimental validation confirmed that estrogen receptor activity is critical for maintaining HIV latency.

Conclusions:

• The estrogen receptor is a potent molecular target for reversing HIV latency.
• Combining therapies that target the estrogen receptor with other latency-reversing agents may offer a promising strategy for HIV cure.